The buccal route has been used as alternative for delivery of drugs that undergo first-pass metabolism or are susceptible to pH and enzymatic degradation. However, the drug concentration absorbed in the buccal mucosa is often low. The encapsulation of drugs into nanoparticles is an important strategy to improve their buccal delivery. In a recently published review paper in Journal of Controlled Release, Ana Macedo, Pedro Fonte (BERG-iBB) and colleagues overview the nanotechnological approaches developed so far to improve the buccal delivery of drugs. Several types of delivery strategies are addressed and a special focus is placed on pipeline products.
Your new post is loading...